Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5027 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 16 out of 35
344 citations found

Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB

Larabee, JL;Bland, SJ;Hunt, JJ;Ballard, JD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

Stutz, A;Kolbe, CC;Stahl, R;Horvath, GL;Franklin, BS;van Ray, O;Brinkschulte, R;Geyer, M;Meissner, F;Latz, E;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Sublingual targeting of STING with 3’3′-cGAMP promotes systemic and mucosal immunity against anthrax toxins.

Martin, TL;Jee, J;Kim, E;Steiner, HE;Cormet-Boyaka, E;Boyaka, PN;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma

Zhai, Z;Liu, W;Kaur, M;Luo, Y;Domenico, J;Samson, JM;Shellman, YG;Norris, DA;Dinarello, CA;Spritz, RA;Fujita, M;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells

Lu, F;Mosley, YC;Rosales, RJ;Carmichael, BE;Elesela, S;Yao, Y;HogenEsch, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Stability and pre-formulation development of a plant-produced anthrax vaccine candidate

Jones, RM;Burke, M;Dubose, D;Chichester, JA;Manceva, S;Horsey, A;Streatfield, SJ;Breit, J;Yusibov, V;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Proteins adopt functionally active conformations after type III secretion

Metcalf, KJ;Bevington, JL;Rosales, SL;Burdette, LA;Valdivia, E;Tullman-Ercek, D;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Enzyme-linked immunosorbent assay (ELISA):

    Samples were grown overnight in LB-L media, then subcultured 1:100 in LB-L media and grown for 8 h at 37 C and 225 rpm. The cultures were pelleted by one centrifugation step of 2272g for 10 min and the supernatant was passed through a 0.45 m filter. The wells of a 96-well microtiter plate (Santa Cruz Biotechnology, Inc., part# sc-204463) was coated with 100 L of a solution of 4 g mL1 protective antigen (PA) of the anthrax toxin (List Biological Laboratories, part# 171E) in 5 mM HEPES, 50 mM NaCl, pH 7.5 covered at 4 C overnight. Liquid was removed by inversion and wells were incubated with a 200 L blocking solution (200 L 2% milk, 0.05% TBST) at room temperature for 1 h. …